U.S. Luxury Stock News

Urban Outfitters, Inc. ( NASDAQ:URBN ) shares have had a really impressive month, gaining 26% after a shaky period...

With the business potentially at an important milestone, we thought we'd take a closer look at Aprea Therapeutics...

Inspired Entertainment, Inc. ( NASDAQ:INSE ), is not the largest company out there, but it received a lot of attention...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Insiders who acquired US$6.90m worth of Hong Kong Pharma Digital Technology Holdings Limited's ( NASDAQ:HKPD ) stock at...

Wingstop Inc. ( NASDAQ:WING ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...

Key Insights Given the large stake in the stock by institutions, Sera Prognostics' stock price might be vulnerable to...

The fact that multiple Integer Holdings Corporation ( NYSE:ITGR ) insiders offloaded a considerable amount of shares...

Those holding Lifetime Brands, Inc. ( NASDAQ:LCUT ) shares would be relieved that the share price has rebounded 32% in...

Despite an already strong run, Dine Brands Global, Inc. ( NYSE:DIN ) shares have been powering on, with a gain of 26...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Those holding Frontier Group Holdings, Inc. ( NASDAQ:ULCC ) shares would be relieved that the share price has rebounded...

Over the past year, many Lennox International Inc. ( NYSE:LII ) insiders sold a significant stake in the company which...

We can readily understand why investors are attracted to unprofitable companies. For example, VirnetX Holding...

Energy Services of America Corporation ( NASDAQ:ESOA ) shares have had a horrible month, losing 26% after a relatively...

MYR Group's (NASDAQ:MYRG) stock is up by a considerable 18% over the past three months. Given that stock prices are...

Wondering if AtriCure at around $35 is quietly setting up a value opportunity, or if the market already has it priced just right? You are not alone in asking whether now is the moment to pay closer attention. The stock is up 16.2% year to date and 3.8% over the last month, even though it is still slightly down over 1 year and meaningfully lower over 3 and 5 years. This pattern hints at shifting sentiment and fresh expectations. Recent headlines have focused on AtriCure's progress in cardiac...

If you are wondering whether MannKind at around $5.59 is a hidden opportunity or a value trap, you are not alone, and that is exactly what we are going to unpack. The stock has slipped around 15.3% year to date and 17.8% over the past year, but it is still up 18.9% over 3 years and 98.2% over 5 years, which highlights how sentiment and risk perception have shifted over time. Recent attention on MannKind has centered on its inhaled insulin Afrezza and its expanding footprint in pulmonary...

TC Bancshares (TCBC) has just posted its Q3 2025 numbers, with revenue at about $4.9 million, basic EPS of $0.08 and quarterly net income of roughly $0.33 million, setting the tone for a cautiously constructive update. The company has seen revenue move from around $4.1 million in Q3 2024 to about $4.9 million in Q3 2025, while basic EPS shifted from roughly $0.06 to $0.08 over the same period, giving investors a clearer read on how recent profitability trends are feeding into the latest...

Wondering if Verisk Analytics is finally trading at a price that makes sense, or if the recent share moves are just noise in a data heavy story? The stock has inched up about 0.4% over the last week and 4.4% in the last month, but that comes after a tough stretch with shares still down 17.8% year to date and 22.4% over the past year, even though the three year and five year returns remain positive at 25.2% and 19.9% respectively. Recently, investors have been digesting updates around...

United Natural Foods (UNFI) opened fiscal Q1 2026 with revenue of about $7.8 billion and a basic EPS loss of roughly $0.07, alongside a trailing 12 month EPS of around negative $1.67 and net income of negative $101 million, keeping the bottom line in the red despite steady sales. The company has seen quarterly revenue move from $7.9 billion in Q1 2025 to $7.8 billion in Q1 2026, while basic EPS losses narrowed from about $0.35 a year ago and sat against a trailing 12 month revenue base of...

Kura Oncology recently reported that it completed the first U.S. commercial sale of KOMZIFTI (ziftomenib), its newly FDA-approved oral menin inhibitor for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, which also triggered a US$135,000,000 milestone payment from partner Kyowa Kirin expected before year-end 2025. This first sale, combined with KOMZIFTI’s inclusion in NCCN guidelines as a Category 2A recommended option, signals early clinical acceptance and provides an...